Tesaro
Latest round
- Series B
Last raised
- Jun 2011
Total raised
- $60M
Investors
- 8
About Tesaro
Founded in 2010 by Mary Hedley in Waltham, US, Tesaro, Inc. specializes in oncology therapeutics.2 mn through the sale of shares.Tesaro, Inc. focuses on the development and commercialization of innovative oncology therapies, particularly PARP inhibitors, which are essential in treating ovarian cancer and other malignancies. These therapies inhibit the enzyme poly(ADP-ribose) polymerase, aiding in cancer cell damage and enhancing treatment efficacy.Tesaro is exploring opportunities for future growth by expanding its portfolio of oncology products, particularly aiming to introduce innovative treatments in the coming years. The company plans to penetrate new geographic markets, focusing on regions like Europe and Asia by 2025.
Who invested in Tesaro
8 investors across 2 rounds
See all investors in Tesaro
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tesaro
Who invested in Tesaro?
Tesaro has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tesaro raised?
Tesaro has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Tesaro last raise money?
Tesaro's most recent round on record is a Series B, in Jun 2011.
What does Tesaro do?
Founded in 2010 by Mary Hedley in Waltham, US, Tesaro, Inc.
Where is Tesaro headquartered?
Tesaro is headquartered in Waltham, US.
Which VCs invest in companies like Tesaro?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Tesaro's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Tesaro? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.